|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/28 | |
| A61P 3/10 |
| (11) | Number of the document | 1802329 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05792052.2 |
| Date of filing the European patent application | 2005-10-05 | |
| (97) | Date of publication of the European application | 2007-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/055017 |
| Date | 2005-10-05 |
| (87) | Number | WO 2006/037789 |
| Date | 2006-04-13 |
| (30) | Number | Date | Country code |
| 200401519 | 2004-10-05 | DK |
| (72) |
BERGLUND, Petter, SE
HAMMELEV, Charlotte, DK
ESKILDSEN, Lone, DK
MADSEN, Johanne, DK
OLSEN, Helle, Aalund, DK
KIMER, Lone, L gstrup, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |
| A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |